Replies to post #80078 on Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

Lastly, the capability to obtain the necessary funding/financing will now only increase as the company hits their milestones (I would not want any dilutive deals to occur down at these prices....we had enough dilution already).

That is not what is stated in the letter. 'Evaluation' of a variety of funding options is ongoing. Dilution is NOT ruled out.

debt, equity

There is no assurance made by Gerald that reaching milestones WILL result in other funding options becoming availible. They need the funds to be able to operate "over the foreseeable future"....toward reaching major milestones.

Also, Gerald's 'belief' of what constitutes a 'major milestone' may not be shared by those from whom he is seeking funding.

We are evaluating a variety of financing options including joint ventures, licensing, debt, equity and grant funding to give the Company sufficient capital to operate over the foreseeable future as our products reach major milestones.